Tuesday, October 09, 2012
Memorial Responds to Questions Regarding Meningitis Outbreak
In reference to the recent outbreak of fungal meningitis, Memorial Healthcare is confident that it has not received or dispensed any of the potentially contaminated steroid medication within the hospital or at its Pain Clinic.
“The national outbreak of fungal meningitis is unfortunate as all healthcare providers administer medications with the intent of helping their patients live a good quality of life,” says Wael Salman, M.D., Vice President of Medical Affairs with Memorial Healthcare.
The four clinics in Michigan which have been identified as having received suspected lots of Methylprednisolone Acetate (PF) recalled from New England Compounding Center on September 26, 2012 are the Michigan Neurosurgical Institute in Grand Blanc; Michigan Pain Specialists in Brighton; Neuromuscular & Rehabilitation in Traverse City; and Southeast Michigan Surgical Hospital in Warren.
According to the Centers for Disease Control (CDC), the potentially contaminated injections were given starting May 21, 2012. Symptoms that should prompt an immediate visit to a physician include: fever, new or worsening headache, neck stiffness, sensitivity to light, new weakness or numbness, increasing pain, redness or swelling of the injection site. Some patients have experienced stroke symptoms such as slurred speech or trouble talking, paralysis or weakness on one side of the body, confusion, blurry vision, and loss of balance. It has been noted by the CDC that this type of fungal meningitis is not contagious.
For additional updates, Memorial Healthcare encourages residents to continue to monitor this situation by visiting the Centers for Disease Control website at http://www.cdc.gov/HAI/outbreaks/meningitis.html